Prolactin receptor gene expression in rat splenocytes and thymocytes during oestrous cycle, pregnancy and lactation by Güneş, Hatice & Mastro, Andrea M.
Cell Prolif 1997, 30, 219-235 
Prolactin receptor gene expression in rat splenocytes and 
thymocytes during oestrous cycle, pregnancy and lactation 
H. Giine2 and A. M. Mastro" 
Izmir Institute of Echnolou, Department of Biology, Izmir; Turkey and 'The Pennsylvania State 
University, Department of Blochemisty and Molecular Biology, Unisersity Park, Pennsyhania, USA 
(Received 1 1 August 1997: accepted 25 A~igust 1997) 
Abstract. Much evidence suggests that prolactin (PRL) has an immunoregulatory 
function. Part of this evidence is that the receptors for PRL are present on lympho- 
cytes. Probably the effects of PRL on cells of the immune system depend on the 
level and specific forms of PRL-R present on the target cells. Therefore, PRL-R 
expression at both protein and mRNA levels was examined during oestrous cycle, 
pregnancy and lactation using Western blotting and PCR analysis. Antibody to the 
long form of PRL-R detected 84 and 42 kDa protein bands in the spleen but only 
84 kDa band in the thymus. The expression pattern of these two protein bands was 
different in the spleen, suggesting that these two isoforms of PRL-R long form are 
differentially regulated by the hormones of oestrous cycle. In addition, depending on 
the tissue, the level of mRNA for the short and long forms of PRL-R showed a 
significant change at different stages of  oestrous cycle. Moreover, 42 and 84 kDa 
PRL-R bands were detected in both spleen and thymus throughout the pregnancy 
and lactation; however, the expression pattern of 84 kDa protein band was different 
between tissues. This finding suggests that each tissue exhibits differential response 
to hormones which affect PRL-R content. 
An anterior pituitary hormone PRL is primarily responsible for the development of 
mammary gland and the stimulation of milk protein genes. In addition, it has effect on 
reproduction, growth, metabolism, behaviour and immunoregulation. Immunoregulatory 
function of PRL has been supported by many studies. For example, decreased antibody 
production as well as cell mediated immunity have been observed in hypohysectomized rats 
(Nagy & -Berczi 1978). Administration of PRL or implantation of pituitary gland reconsti- 
tuted these immune functions (Berczi et al. 1981, Nagy et al. 1983). In addition, PRL has 
been shown to regulate DNA synthesis in vivo in lymphoid tissue (Berczi et al. 1991) and to 
act directly on splenocytes and thymocytes in vitro (Mukherjee et al. 1990, Viselli, Stanek & 
Mukherjee 1991). 
PRL-R expression has been shown in lymphoid cells. For example, binding studics with 
'2sI-labelled PRL provided evidence that human T- and B-cells have PRL-R (Russell 1985). 
More definitive studies based on the use of antibodies to PRL-R and flow cytometry 
confirmed these findings; and indicated that many subsets of rat splenocytes (Viselli & 
Mastro 1Y93), rat and murine lymphoid cells (Koh & Phillips 1YY3, Gagnerault et al. 1993) 
Correspondence: Dr H. Giineg, Department o f  Biology, izmir Institute of Technology, Gaziosinanpasa 
Bulv. No. 16, Cankaya 35210 Izmir, Turkey. E-mail: ligunes(cLlikya.iyte.edu.tr 
0 1997 Blackwell Sciencc Lirnitcd. 219 
220 H. Ciinef and A .  M.  Mastro 
display PRL-R. By using in-situ hybridization and polymerase chain reaction, the long and 
the short forms of PRL-R have been detected in rat spleen and thymus (Ouhtit et af .  1993, 
GiineS et af .  1993, Touraine et af. 1994). 
The short and long forms of PRL-R have been identified from normal rat liver and ovary 
(Shirota et al. 1990). These two receptors differ in the length and the sequence of the 
intracellular region. The short form (291 amino acids) is encoded by 1.8 kb (kilobase) 
transcript. However, the long form (591 amino acids) is encoded by three transcripts which 
are 2.5, 3, and 5.5 kb. Alternative splicing of a primary transcript appears to be responsible 
for these different mRNAs (Kelly, Ali & Rozakis 1993). An intermediate form of PRL-R has 
only been found in a rat lymphoma cell line, Nb2 (Shiu ef ul. 1983). 
Hormonal expression and regulation of PRL-R have been the subject of several studies in 
many different tissues such as ovary, mammary gland, liver and brain (Jahn et af .  1991, 
Clarke & Linzer 1993, Clarke et af. 1993, Guillaumot & Cohen 1994, Sugiyama et al. 1994). 
However, less is known about PRL-R expression and regulation in lymphoid tissues. Because 
only lymphocytes from rats in certain hormonal states respond to PRL, it is possible that the 
effects of PRL on cells of immune system may depend on the level and specific forms of 
PRL-R on the target cells. Therefore, the aim of this study was to examine PRL-R expres- 
sion during the oestrus cycle, pregnancy and lactation in rat splenocytes and thymocytes. 
M A T E R I A L S  A N D  M E T H O D S  
Animals 
Sprague-Dawley rats or pregnant rats (Harlan Laboratories, Indianapolis, IN) were housed 
in a room maintained at 20-22°C on a 14 h light, 10 h dark schedule with free access to food 
and water. Daily vaginal smears were taken to determine the stage of oestrus cycle. Only 
animals with a regular 4-day cycle were chosen for experiments. All rats were sacrificed 
between 11 and 12 am. The day when spermatozoa appeared in the vaginal smear was 
designated as day 0 of pregnancy. 
Isolation of splenocytes and thymocytes 
Rats were decapitated, the spleens and thymi removed, and placed in sterile saline. Cells 
were isolated as described previously (GiineS et al. 1993). Cell counts were performed with 
a haernacytometer and viability determined by trypan blue exclusion. Cell viability averaged 
85% for splenocytes and 96% for thymocytes. 
RNA isolation 
Total cytoplasmic RNA was extracted from a range of 2 x 10' to 1 x cells by the 
guanidinium thiocyanate method of Chomczynski & Sacchi (1 987). Isolated RNA pellets 
were suspended in ribonuclease free water and quantified by spectrophotometry. 
Primer design 
Primers were designed and prepared (Oligo Synthesis by the Biotechnology Institute, The 
Pennsylvania State University, PA) in order to differentiate the mRNA of the long form of 
the PRL-R from the short form (Figure 1). The 5' primer, TACATCGTTGAGCCCAGAG 
(352-370), was taken from a region preceding the transmembrane region. The sequences for 
both forms are homologous (Boutin et af .  1988). The sequences of the long and short forms 
diverge in their cytoplasmic regions. The short form 3' primer, AGTCTGCAGCTT- 
CAGTAG (927-944), was taken from the sequences of the final 30 amino acids of the short 
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Figure 1. Peptide and primer design for antibody production and PCR of the long and short forms of 
PRL-R. 3' primers were designed using non-homologous sequences in order to differentiate the long 
and short from mRNA. For antibody production, amino acid sequences were chosen from 
non-homologous sequences to distinguish the short and long forms. 
form. The long form 3' primer, CTGTCATAGCTTCCGTGA (1037-1054) (Shirota et al. 
1990), is from sequences after the short form stops. The expected PCR products using these 
primers are 701 base pairs for the long form and 593 base pairs for the short form. Actin 
primers (5' primer CACTGGCATTGTGATGGA; 3' primer ACGGATGTCAACGTCACA) 
were chosen from the sequences of rat ,&actin gene (Nude1 et al. 1983) to produce 427 base 
pair PCR product. 
Reverse transcription and PCR amplification (RT-PCR) 
Total RNA was reverse transcribed to cDNA as described previously (GiineS et al. 1993). 
Briefly, 10 pg RNA was added to a reaction mixture of 0.75 pg random hexamers, 0.02 U of 
RNAsin, 75 p~ of each dNTP, buffer (50 mM Tris HCI, pH 8.3; 75 mM KCI; 3 mM MgCl,), 
0.1 mM DTT and 200 U of M-MLV reverse transcriptase (Gibco BRL, Gaithersburg, MD). 
The cDNA was amplified using 2.5 U of Taq Polymerase (Perkin Elmer, Norwalk, CT) in a 
Thermocycler programmed with the following cycles: Cycle 1: 3 rnin at 94T,  2 min at 5WC, 
2 min at 72°C Cycles 2 through to 38; 1 min at 94"C, 1 rnin at 50°C, 2 min at 72°C; and Cycle 
40; 1 min at 94"C, 1 rnin at 50"C, 10 rnin at 72°C. A sample without cDNA served as negative 
control. After amplification, PCR products were kept at - 20°C until used. A linear relation- 
ship between the log of RNA input (5, 10 and 20 pg) and the log of the chemiluminescent 
signal was observed previously (GuneS & Mastro 1996). 
Southern blot analysis 
The amplified cDNA was electrophoresed through a 1.5% agarose gel containing ethidium 
bromide and transferred to Immobilon-S membrane (Millipore, Beverly, MA). The 
membrane was hybridized with biotinylated cDNA probes for PRL-R or actin as described by 
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GiineS & Mastro (1996). The membrane was exposed to Polarplex Chemiluminescent 
reagents (Milipore, Beverely, MA) and XAR X-ray film for detection of the bands. 
Quantification of PRL-R bands 
In order to compare relative levels of the two forms of PRL-R, primers for actin, a house- 
keeping gene, were included in PCR reaction. The Southern blots were scanned by densito- 
metry (Quick Scan Jr., Helena Laboratories, Beamont, TX). Quantitative analysis of mRNA 
for PRL-R was carried out by normalizing the densitometric signal for the short or long form 
with that of the actin. Also PRL-Rs detected with Western blotting were quantified in similar 
fashion. 
Solubilization of lymphocyte proteins 
Solubilization of membrane and cytoplasmic proteins of lymphocytes was carried out as 
described by Coligan et al. (1991). Briefly, cells were suspended at 2 x lo7 cells in 5 ml 
ice-cold PBS and centrifuged for 5 min at 500g, 4°C. The pellet was resuspended in 200 p1 
Triton X-100 lyses buffer (300 mM NaCl, 50mM Tris-C1 pH 7.6, 0.5% Triton X-100) with 
protease inhibitors, 1 mM PMSF (phenylmethyl sulfonylfluoride), 10 pglml aprotinin, 10 pglml 
leupeptin and kept on ice for about 1 h. The samples were microcentrifuged for 15 min at 
10000g at 4°C. Supernatants were aliquoted at 50 p1 and kept -20°C until used. 
Western blot analysis 
Solubilized membranes and cytosolic proteins were separated on 10% SDS-polyacrylamide 
gel electrophoresis (Laemmli 1970) and electrophoretically transferred (150 mA, 1 h, 0.9 
mA/cm2) to PVDF (polyvinylidene difluoride) membrane (Millipore, Beverely, MA) using a 
graphite plate electroblotting apparatus (Andersen 1984). Prestained molecular weight 
markers were electrophoresed and electroblotted as well. The membrane was incubated 
either with a monoclonal antibody U6 to PRL-R (a generous gift from Dr Paul Kelly, 
INSERM, Paris, France) or with a polyclonal antibody to the long form of PRL-R (Figure 1) 
produced and characterized by GiineS 1995; GiineS & Mastro (1996) or with an anti-actin 
mAb (Oncogene Science, Uniondale, NY) or with pre-immune rabbit serum as negative 
control. Protein bands were detected with an ECL Western blotting kit (Amersham, 
Arlington Heights, IL). 
RESULTS 
Prolactin receptor expression during the rat oestrus cycle 
Lysates of splenocytes from rats at pro-oestrus and di-oestrus were subjected to Western blot 
analysis to determine how different hormonal states affected PRL-R expression at protein 
level. As it was shown in our previous study (GuneS & Mastro 1996), the polyclonal 
antibodies produced against the long form of the PRL-R recognized two protein bands with 
molecular mass of 42 kDa and 84 kDa in the rat splenocytes (Figure 2a). The expression of 
relative amount of 42 kDa and 84kDa bands exhibited different pattern during oestrous cycle 
(Figure 2b). For example, the level of 42 kDa band was at its highest level during pro-oestrus 
but decreased by 1.6-fold during oestrus and twofold during di-oestrus. However, the level of 
the 84 kDa band was at its lowest during pro-oestrus and increased by twofold and sixfold 
during oestrus and di-oestrus, respectively. The amount of 42 kDa band displayed no signifi- 
cant change during various stages of oestrous cycle (Table 1). However, the level of 84 kDa 
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Figure 2. Western blot analysis of PRL-R cxprcssion in splenocytes during the rat oestrus cycle. 
Splenocytes 2 x 10- from rats at pro-oestrus ( I  ), oestrus (2), and di-oestrus (3) stages of the oestrus cycle 
were lysed in 200 it1 lysis buffer. Cell lysate 20  111 from each group was subjected t o  10% SDS-PAGE, 
transfered onto PVDF membrane. Protein hands were detected with antibody to the long form of  
PRL-R (1/1000) and actin (2 Itgiml) antibodics using the ECL method. (a) Western blot analysis. (b) 
Normalization of the level of PRL-R to that of actin. P, pro-oestrus; E, oestrus; D, di-oestrus. Data are 
the average i S E M  of four rats. 
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Table 1. Relative levels of 42 kDa and 84 kDa bands detected with antibody to the long form of PRL-R 
during oestrus cycle 
Oestrus cycle 84 kDa in spleen 42 kDa in spleen 84 kDa in thymus 
Pro-oestrus 
Oestrus 
Di-oestrus 
8 ( f0 .8)  50 (k 10) 
17 ( f3)"  30 ( $ 6 )  
46 (k 13Yh 25 ( $ 7 )  
50 (f 11) 
170 (k41)" 
100 ( f  12) 
PRL-R levels, detected with Western blotting, during at various stages of the oestrus cycle. Data are 
the mean &SEM of four rats. Statistical analysis was done using a one-way analysis of variance with 
Tukeys post hoc test to detect the differences between different stages of the oestrous cycle. The 
significant differences (P  < 0.05) between groups were shown by different letters. Different from 
pro-oestrus. Different from oestrus. 
band changed significantly in oestrus and di-oestrus compared with pro-oestrus; and in 
oestrus compared with di-oestrus. 
In thymocytes, only the 84 kDa band was detected with antibodies to the long form of 
PRL-R (Figure 3a). The amount of the 84 kDa band was relatively low at pro-oestrus; 
however, it increased three- and twofold at oestrus and di-oestrus, respectively. These results 
indicated that unlike in the spleen 84 kDa band exhibited a significant change only during 
oestrus compared to pro-oestrus and di-oestrus in the thymus (Table 1). Moreover, the level 
of the 84 kDa band peaked during di-oestrus in the spleen but at oestrus in the thymus. 
In addition to the protein levels, mRNA levels of PRL-R short and long forms were 
examined during various stages of oestrous cycle. PCR analysis of total RNA from spleno- 
cytes (Figure 4a) indicated that the relative level of the long form mRNA was higher than 
that of the short form mRNA (Figure 4b) at all the stages of oestrous cycle. The level of the 
long form mRNA was the highest during pro-oestrus. A dramatic decrease (1.8-fold and 
1.5-fold) was observed during oestrus and di-oestrus as compared to that in pro-oestrus 
(Table 2). On the other hand, the amount of mRNA for the short form did not significantly 
change at different stages of oestrous cycle. 
In contrast to splenocytes, thymocytes did not show a significant change in the amount of 
the long form mRNA during the oestrous cycle (Table 2). Moreover, unlike in splenocytes, 
the relative levels of short form mRNA declined significantly during oestrus in comparison 
with pro-oestrus and di-oestrus in thymocytes. 
Prolactin receptor expression during pregnancy and lactation 
Western blot analysis with antibodies to the long form PRL-R indicated the presence of both 
84 kDa and 42 kDa bands in the spleen throughout the pregnancy and lactation (Figure 5a). 
Densitometric analysis of Western blots revealed that the relative amount of 42 kDa band 
was 51 at the beginning of pregnancy (Figure 5b). Then, it decreased twofold during 
mid-pregnancy (day 10) and increased 1.5-fold toward the end of pregnancy (day 20). It rose 
to the highest level during lactation day 8 and day 14. Toward the end of lactation (day 22), 
the level of 42 kDa band decreased sharply (2.2-fold). 
The relative amount of the 84 kDa band remained low during day 1 and 10 of pregnancy 
(Figure 5b). However, it started to increase at day 20 and reached to the highest level during 
lactation day 8. There was a rapid decrease at day 14 of lactation. At the end of lactation, it 
further decreased to the level, almost the same level as at day 20 of pregnancy. 
The 84 and 42 kDa bands showed similar patterns during pregnancy and lactation (Figure 
5b). For example, the levels of both protein bands were low at day 10 of pregnancy, reached 
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Figure 3. Western blot analysis of PRL-R expression in thymocytes during the rat oestrus cycle. Samples 
are exactly as described in the legend to Figure 1 except that thymocytes were used. (a) Western blot. 
(b) Normalization of the level of PRL-R to that of  actin. P, pro-oestrus; E, oestrus; D, di-oestrus. Data 
are the average *SEM of four rats. 
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Figure 4. PRL-R mRNA expression in splenocytes during the rat oestrus cycle. Total RNA 10 p g  from 
rats at pro-oestrus (P), oestrus (E), and di-oestrus (D) was reverse transcribed to cDNA. Ten per cent 
of each cDNA reaction was used in 40 cycles of PCR amplification. After separation on an agarose gel, 
PCR products were transferred to an immobilon membrane and hybridized with biotinylated probes. (a) 
Southern blot analysis of PCR products. Lanes 1, 2, 3 are P, E, D for the long form; lanes 4, 5 ,  6 are 
P, E, D for the short form; lanes 7, 8, 9, 10, 11, 12 are the repeat of the experiment in the same order 
as above. (b) Normalization of PRL-R level with the level of actin. Data are the average i S E M  of 
three rats. 
01997 Blackwell Science Ltd, Cell Proliferution, 30, 219-235. 
Prolactin receptor gene expression 227 
Table 2. Relative levels of PRL-R short and long form mRNA during the oestrous cycle in splenocytes 
and thymocytes 
~ 
Oestrus Long form Short form Long form Short form 
cycle in spleen in spleen in thymus in thymus 
Pro-oestrus 100 (f0) 28 (k2.5) 70 (k 13) 34 (f1) 
Di-oestrus 65 (k3)" 20 (k2.0) 40 ( f 3 )  34 ( f 3 )  
Oestrus 55 (k5y 17 (kl.5) 50 ( + O t  27 ( +OPh 
~ ~ 
PRL-R levels, detected with PCR, during at various stages of oestrus cycle. Data are the mean f SEM 
of three rats. Statistical analysis was carried out as described in the legend to Table 1. The significant 
differences (P < 0.05) between groups were shown by different letters. Different from pro-oestrus. 
Different from di-oestrus. 
a maximum during the early stage of lactation (day 8) and decreased continuously as 
lactation progressed (Figure 6a). 
In contrast to spleen, only the 84 kDa band was detected in the thymus during pregnancy 
and lactation (Figure 7a). The level of 84 kDa band gradually decreased with progression of 
pregnancy. After parturition, the level increased markedly 10-fold, ninefold and 17-fold 
during days 8, 14 and 22 of lactation, respectively (Figure 7b). This expression pattern of 
PRL-R in the thymus differs from that of PRL-R in the spleen (Figure 6a & b) in that at the 
end of lactation the level of 84 kDa band increased twofold in the thymus, but it decreased 
in the spleen. 
In addition, PRL-R expression was examined using a monoclonal antibody U6, known to 
recognize the short form (Okamura et al. 1989). We noted that proteins (38-40 kDa) 
detected using U6 were not recognized by antibodies to the long form of PRL-R. Therefore, 
all the Western blots were stripped and relabelled with U6. The pattern of the expression of 
PRL-Rs detected with U6 and the antibodies to the long form of PRL-R was similar in both 
tissues (data not shown). 
D I S C U S S I O N  
In this study, we investigated the PRL-R expression during different hormonal states. 
Antibodies to the long form of PRL-R revealed two protein bands at 42 and 84 kDa in the 
spleen (probably two different isoforms of the long form of the PRL-R) but only 84 kDa in 
the thymus as it was shown previously (GuneS & Mastro 1996). The level of 84 kDa band 
increased during oestrus and di-oestrus in both tissues; whereas it decreased during 
pro-oestrus. Based on previous studies, plasma concentration of LH, FSH, PRL, proges- 
terone and oestradiol peaks during the pro-oestrus stage of the rat oestrus cycle (Butcher, 
Collins & Fuge 1974, Freeman 1988). Therefore, it seems that elevation of all these hormone 
levels at pro-oestrus results in a decrease in expression of 84 kDa PRL-R in both spleen and 
thymus. 
In contrast to the 84 kDa protein, the 42 kDa protein reached to its maximum during 
pro-oestrus and decreased at  oestrus and di-oestrus. These results indicate that these two 
isoforms of PRL-R long form are differentially regulated in the spleen by the hormones of 
oestrus cycle. This finding is consistent with the results of Guillaumot & Cohen (1994) who 
found, by using the binding of '251-labelled ovine PRL, four different molecular forms of 
PRL-R, 80, 50, 40 and 16 kDa which varied according to the physiological stages in the 
mammary gland. For example, the 40 kDa form was present during all the stages of the 
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cpression in splenocytes during pregnancy and lactation. Figure 5. Western blot analysis of PRL-R 
Splenocytes 2 x 10’ from 1 day (l) ,  10 days ( 2 ) ,  and 20 days (3) pregnant rats; rats lactating for 8 days 
(4), 14 days (5 ) ,  and 22 days (6) were lysed in 200 pl lysis buffer. Twenty microlitres of cell lysate from 
each group was subjected to Western blotting as described in the legend to Figure 1. (a) Western blot 
analysis. (b) Normalization of the level of PRL-R to that of actin. Data are the average kSEM of three 
rats. 
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Figure 7. Western blot analysis of PRL-R expression in thymocytes during pregnancy and lactation. 
Samples are exactly as described in the legend to Figure 5 except that thymocytes were used. (a) 
Western blotting. (b) Normalization of the level of PRL-R to that of actin. Experiment was repeated 
twice with similar results. 01997 Blackwcll Science Ltd, Cell Proliferation, 30, 219-235. 
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oestrus cycle; however, the 50 kDa form was observed only during pro-oestrus; and 16 kDa 
form was present only during lactation. 
We found that the level of 84 kDa PRL-R in thymus reached its maximum level at oestrus, 
a result consistent with the previous studies (Guillaumot et al. 1984) that PRL-R levels rose 
to their maximum level in the mammary gland during the day of oestrus. Likewise, the 
amount of 84 kDa PRL-R in the spleen was also relatively high during oestrus and di-oestrus 
as compared to pro-oestrus in this study. Previous reports indicated that steroid hormones as 
well as PRL alter the cellular concentration of PRL-R (Posner 1976, Barkey et al. 1981, 
Ormandy & Sutherland 1993). At this point, we cannot determine which of these hormones 
caused the change in PRL-R protein in spleen and thymus during different stages of oestrus 
cycle. In fact, all hormones, oestradiol, LH, FSH, PRL and progesterone, increase during the 
day of pro-oestrus (Butcher et al. 1974, Freeman 1988) and probably each hormone alone or 
in synergy with others may be involved in the alteration of PRL-R level during the oestrus 
cycle. 
Differential regulation of the long forms of PRL-R levels during various stages of the 
oestrus cycle may be one of the possibilities for the in vitro finding of a mitogenic effect of 
PRL on splenocytes from rats at dioestrus and from ovariectomized rats. However, this needs 
to be confirmed in further studies. It is also possible that the level of short form of the 
PRL-R may have an important function for PRL-responsiveness of splenocytes because both 
the short and long forms of PRL-R have been shown to signal cells to grow in the presence 
of PRL (Banerjee & Vonderhaar 1994). 
In addition to the protein level of the PRL-R, the mRNA levels for the short and the long 
forms of the PRL-R were examined during the rat oestrus cycle. The mRNA for the long 
form of PRL-R was present in greater quantities than that of the short form of PRL-R at all 
the times during the oestrus cycle (Table 2). These results are consistent with those of 
Sugiyama et al. (1994) who showed that the level of the long form of the PRL-R mRNA was 
greater than that of the short form in rat brain during oestrus cycle; and by Clarke, Arey & 
Linzer (1993) who found the same results in rat ovary. 
In this present study, the maximum level was observed during pro-oestrus for the long 
form of PRL-R mRNA, then the level dropped significantly during oestrus and stayed at the 
similar level during di-oestrus. Similarly, the short form mRNA was at the highest level 
during pro-oestrus but it did not alter significantly during oestrus and di-oestrus (Figure 4). 
The change of the long form of PRL-R mRNA levels may be due to alterations in the rate 
of PRL-R gene transcription or PRL-R mRNA stability as a function of hormonal 
environment. 
High levels of expression of PRL-R long form mRNA during pro-oestrus had also been 
observed in the studies of others. For example, Sugiyama et al. (1994) found that the long 
form of mRNA in rat brain increased twofold during pro-oestrus, and stayed almost at the 
same level during oestrus in comparison with di-oestrus. Similarly, the long form of PRL-R 
mRNA increased during pro-oestrus and oestrus in rat liver (Nagao & Kelly 1992). In 
contrast to these results, we found that the long form mRNA levels in the spleen decreased 
almost twofold during oestrus in the present study. The differences between the results are 
most likely due to the different tissues used in these studies. The results also show that the 
same hormones exert different effects on different tissues. This significant increase of PRL-R 
long form mRNA during pro-oestrus at the time during which there is a surge in serum PRL 
and oestradiol levels (Freeman 1988) implies that oestradiol and PRL are involved in the 
induction of the long form mRNA as well as the short form of PRL-R mRNA in the 
spleen. 
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In the thymus, the amount of PRL-R long form mRNA did not significantly change during 
the oestrus cycle. However, the short form of PRL-R mRNA decreased during oestrus but 
remained at the highest level during pro-oestrus and di-oestrus (Table 2). These results 
indicated that hormonal regulation of PRL-R mRNA expression is tissue specific. As in the 
spleen, the long form of PRL-R mRNA was at higher quantity than the short form mRNA 
during every stage of the oestrus cycle in thymus. 
When the protein level of PRL-R in the spleen (Fig. 2) was compared to the level of 
PRL-R mRNA (Fig. 4), it was observed that the level of long form of mRNA paralleled the 
level of 42 kDa band during the oestrus cycle. However, the 84kDa band exhibited an 
opposite pattern to the long form mRNA. These findings indicate that PRL-R expression is 
regulated at both transcriptional and translational level during different hormonal states. In 
other words, both 84 kDa and 42 kDa PRL-R are present in the spleen, and an increase in 
the expression of either one or the other depends upon the hormonal environment. Indeed, 
previous investigators reported that post-translational regulation of PRL-R protein was 
mediated through steroid hormones. For instance, PRL-R protein half-life increased in 
response to progestin (Murphy et al. 1993). Also oestradiol results in an increase in PRL-R 
protein without further increase in PRL-R mRNA level in liver (Jolicoeur, Boutin & 
Okamura 1989). 
Comparison of PRL-R protein with PRL-R mRNA in the thymus (Tables 1 & 2) showed 
that the 84 kDa protein increased significantly during oestrus and di-oestrus but the mRNA 
level for the long form was almost the same at all the stages of the oestrus cycle. This result 
suggests that PRL-R expression in thymus is regulated at translational level during different 
hormonal states. 
In addition to the oestrus cycle, PRL-R expression was examined during pregnancy and 
lactation. In the spleen, the levels of the 42 kDa and 84 kDa proteins were relatively low 
during early stages of pregnancy but increased at the end of pregnancy (day 20) and early 
lactation, then decreased gradually as lactation progressed (Fig. 5). In the thymus, the 
84 kDa PRL-R was relatively high during first day of pregnancy and it decreased sharply 
throughout the pregnancy. It increased dramatically during lactation and continued to rise at 
the end of lactation (Fig. 7). This pattern of PRL-R expression in thymus is similar to those 
reported in mammary gland (Jahn et al. 1991). Although the expression pattern of PRL-R in 
spleen looks similar to that in the liver (Jahn et al. 1991), they do  not parallel exactly. For 
example, PRL-R levels increased during the end of pregnancy in both tissues. However, 
PRL-R level dropped to the lower level throughout the lactation in liver but in the spleen it 
remained high at early stage of lactation and decreased gradually toward the end of lactation. 
These results show that effects of hormones on PRL-R expression are tissue specific. 
In addition, U6 monoclonal antibodies to the PRL-R detected 38 kDa and 40 kDa proteins 
during pregnancy and lactation in both tissues. The pattern of expression of these protein 
bands was similar to that of the long form of the PRL-R in the spleen, i.e. the level was high 
at the beginning of pregnancy and lactation and decreased with progression of these 
hormonal states. 
A rise in PRL-R expression during end of pregnancy and early stages of lactation in spleen 
and thymus is in agreement with the fact that the fall in progesterone levels induces PRL 
secretion (Deis, Corrizo & John 1989) as well as PRL-R expression (Jahn et al. 1991). 
Indeed, Morishige, Pepe & Rothchild (1973) reported that serum concentration of proges- 
terone increase at the early stages of pregnancy in the rat, reaches a maximum around day 
16; and decreases to undetectable level by day 21 of pregnancy. Furthermore, a rapid 
increase in the concentrations of PRL and oestradiol several days before delivery and after 
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birth (Morishige et a/. 1Y73, Neil1 1974, Saunders et a/. 1976) supports the idea that PRL 
secretion during end of pregnancy and the beginning of lactation induces and upregulates 
expression of its own receptor in the spleen and the thymus. 
In conclusion, the expression levels of 42 kDa and 84 kDa protein bands detected with 
antibody to the long form of PRL-R were differentially regulated in the spleen throughout 
the oestrus cycle. In other words, an increase in the expression level of either one or the 
other depends on the stage of the oestrus cycle. Moreover, the level of the long form mRNA 
in the spleen and that of the short form mRNA in the thymus showed significant change at 
different stages of oestrus cycle, indicating that hormonal regulation of PRL-R mRNA 
expression is tissue specific. Furthermore, the expression pattern of 84 kDa PRL-R band was 
different in both spleen and thymus throughout pregnancy and lactation. However, a 
consistent finding was that the level of PRL-R expression increased rapidly at the beginning 
of lactation. As a result, PRL-R expression at both mRNA and protein levels showed a 
change during different hormonal stages and the effect of hormones on PRL-R expression 
was specific to each tissue. 
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